Scancell
John has many years of experience in life science companies and has sat on a number of LSE, NASDAQ, and ASX listed boards. He is Managing Director of Newstar Ventures, a healthcare investment and advisory firm, and contributes strong strategic and corporate finance skills to the Group. John is also Chairman of N4 Pharma plc and Biotherapy Services (as a representative of Foresight Group) and is a Director of Regeneus Limited (ASX).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Scancell
Scancell's mission is to overcome this breach in defenses by developing products that stimulate the immune system to treat or prevent cancer.